Tianjin Chase Sun Pharmaceutical: CSI Enterprise Bond Index's Tianjin Chase Sun Pharmaceutical publicly issued corporate bonds (first phase) for professional investors in 2021. This report is for the entrusted management affairs (2023).
Tianjin Chase Sun Pharmaceutical: Tianjin Hongri Pharmaceutical Co., Ltd. 2024 Follow-up Rating Report
Tianjin Chase Sun Pharmaceutical: 2023 Annual Equity Distribution Implementation Notice
Tianjin Chase Sun Pharmaceutical: 2024 First Quarter Report
Tianjin Chase Sun Pharmaceutical: 2024 First Quarter Report Disclosure Prompt Announcement
Hongri Pharmaceutical: Announcement on the Company's Obtaining a Drug Registration Certificate
Hongri Pharmaceutical: Notice on the Company's Completion of the Registration of the Legal Representative's Change of Trade
Hongri Pharmaceutical: Legal Opinion of the 2023 Annual General Meeting of Shareholders
Hongri Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Hongri Pharmaceutical: 300026 Hongri Pharmaceutical Investor Relations Management Information 20240419
Hongri Pharmaceutical: Legal Opinion of the Third Extraordinary General Meeting of Shareholders in 2024
Hongri Pharmaceutical: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Hongri Pharmaceutical: Announcement on holding the 2023 Online Results Briefing
Hongri Pharmaceutical: Joint Credit Assessment Co., Ltd.'s concern announcement regarding changes in the chairman and general manager of Tianjin Hongri Pharmaceutical Co., Ltd.
Hongri Pharmaceutical: Interim Report of Tianfeng Securities Co., Ltd. on the fiduciary management matters of the resignation of the chairman of Tianjin Hongri Pharmaceutical Co., Ltd. and the by-election of directors, chairman, vice chairman, adjustment o
Hongri Pharmaceutical: Announcement of Resolutions of the 17th Meeting of the Eighth Board of Directors
Hongri Pharmaceutical: Notice on Convening the Third Extraordinary General Meeting of Shareholders in 2024
Hongri Pharmaceutical: Announcement on the Resignation of the Chairman of the Company and the By-election of Directors, Chairman of the Board, Vice Chairman, Adjustment of Special Committee Members, Changes in Legal Representatives, and Appointment of Comp
Hongri Pharmaceutical: Legal Opinion of the 2024 Second Extraordinary General Meeting of Shareholders
Hongri Pharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
No Data